Loading data for MDT — first visit, this takes a few seconds.

Medtronic

NYSE: MDT · Real-Time Price · USD
92.02
+0.88 (0.97%)
At close: Aug 26, 2026, 3:59 PM

The price, the headline numbers and the latest news, in one place.

Medtronic (MDT) Stock Price, Analysis & Data

0.97%
Bid92.24
Market Cap117.78B
Revenue (ttm)36.36B
Net Income (ttm)4.8B
0.57
3.76
24.47
14.37
P/B (ttm)2.38
P/S (ttm)3.24
Earnings DateSep 1, 2026
Ask92.25
Volume5,984,233
Avg. Volume (20D)9,048,804
Open91.08
Previous Close91.14
Day's Range90.75 - 92.53
52-Week Range73.31 - 106.33
Analystn/a
Price Targetn/a
Dividends$2.88 (3.16%)
Ex-Dividend DateSep 25, 2026

About MDT

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization th...

Sector Healthcare
IPO Date May 2, 1973
Employees 95,000
Stock Exchange NYSE
Ticker Symbol MDT
Full Company Profile

Financial Performance

In 2026, Medtronic's revenue was 36.36B, an increase of 8.43% compared to the previous year's 33.54B. Earnings were 4.8B, an increase of 2.98%.

Financial Statements

Earnings Surprise

Medtronic has released their quarterly earnings on Jun 3, 2026:
  • Revenue of $9.81B misses estimates by $0, with 9.86% YoY growth.
  • EPS of 1.55 exceeds estimates by 0.01, with -4.32% YoY decline.
Medtronic is scheduled to release its earnings on Sep 1, 2026, before market opens.
Analysts project revenue of ... Upgrade